InsiderTrades.com logo

TRAX Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,758,286.70

First Tracks Biotherapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at First Tracks Biotherapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

First Tracks Biotherapeutics Share Price & Price History

Current Price: $36.28
Price Change: ▲ Price Increase of +1.82 (5.28%)
As of 10/19/2026 04:00 PM ET

This chart shows the closing price history over time for TRAX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

First Tracks Biotherapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/2/2026J. Anthony WareDirectorSell39,265$44.78$1,758,286.7015,660View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for First Tracks Biotherapeutics (NASDAQ:TRAX)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TRAX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

First Tracks Biotherapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/22/2026State Street Corp1,512,896$30.44M0.0%N/A4.234%Search for SEC Filing on Google Icon
9/9/2026Opaleye Management Inc.65,000$1.31M0.1%N/A0.182%Search for SEC Filing on Google Icon
9/9/2026Tidal Investments LLC30,907$0.62M0.0%N/A0.086%Search for SEC Filing on Google Icon
8/27/2026Corient Private Wealth LP30,339$0.61M0.0%N/A0.085%Search for SEC Filing on Google Icon
8/25/2026VIRGINIA RETIREMENT SYSTEMS ET Al11,550$0.23M0.0%N/A0.032%Search for SEC Filing on Google Icon
8/19/2026Wellington Management Group LLP57,476$1.16M0.0%N/A0.161%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
First Tracks Biotherapeutics is a clinical stage biotechnology company advancing antibody therapies which modulate immune pathways implicated in autoimmune and inflammatory diseases. Its pipeline includes ANB033 and ANB101. First Tracks Biotherapeutics is based in SAN DIEGO.
Read More on First Tracks Biotherapeutics

Today's Range

Now: $36.28
Low: $35.00
High: $37.26

50 Day Range

MA: $38.92
Low: $30.59
High: $46.75

52 Week Range

Now: $36.28
Low: $14.72
High: $49.91

Volume

1,434,177 shs

Average Volume

728,292 shs

Market Capitalization

$1.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of First Tracks Biotherapeutics?

First Tracks Biotherapeutics' top insider shareholders include:
  1. J Anthony Ware (Director)
Learn More about top insider investors at First Tracks Biotherapeutics.

First Tracks Biotherapeutics Active Insiders

J. Anthony Ware
J. Anthony Ware
Director
1 recent trades